Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
17 hedge funds and large institutions have $2.23M invested in Bio-Path Holdings Inc in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 17 → 17 (0)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
24% less capital invested
Capital invested by funds: $2.94M → $2.23M (-$718K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$119K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.2K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.52K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$2.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$77.7K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$76.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$19.8K |
| 4 |
BlackRock
New York
|
-$2.52K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$360 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $1.12M | – | – | – |
|
|
2
BlackRock
New York
| $348K | -$2.52K | -21 | -0.6% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $337K | +$2.52K | +21 | +0.6% |
|
|
4
Morgan Stanley
New York
| $108K | +$119K | +992 | +1,526% |
|
|
5
Northern Trust
Chicago,
Illinois
| $93K | +$2.16K | +18 | +2% |
|
|
6
Dimensional Fund Advisors
Austin,
Texas
| $79K | -$76.5K | -638 | -45% |
|
|
7
Citadel Advisors
Miami,
Florida
| $64K | -$77.7K | -648 | -51% |
|
8
State Street
Boston,
Massachusetts
| $62K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $7K | +$7.2K | +60 | +600% |
|
|
10
UBS Group
Zurich,
Switzerland
| $4K | -$19.8K | -165 | -80% |
|
|
11
Bank of America
Charlotte,
North Carolina
| – | -$360 | -3 | -75% |
|
BPTH Hedge Fund Activity: Q3 2021 in Review
17 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q3 2021, worth a combined $2.23M — down 24% from $2.94M a quarter earlier.
Fund positioning in BPTH was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 4 added to existing stakes and 5 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $119K. The largest seller was Citadel Advisors, cutting an estimated $77.7K.
- 17 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $2.23M of Bio-Path Holdings Inc stock for Q3 2021, down 24% quarter-over-quarter.
- 0 funds opened new Bio-Path Holdings Inc positions in Q3 2021 and 0 closed out.
- The largest Bio-Path Holdings Inc buyer in Q3 2021 was Morgan Stanley, an estimated $119K added.
- The largest Bio-Path Holdings Inc seller in Q3 2021 was Citadel Advisors, an estimated $77.7K sold.
Based on aggregated 13F filings for Q3 2021.